Studies on assays for plasma prekallikrein and for the monitoring of coumarol therapy
- PMID: 149049
- DOI: 10.1159/000214240
Studies on assays for plasma prekallikrein and for the monitoring of coumarol therapy
Abstract
Chromogenic substrates were used to assay prekallikrein, prothrombin and factor X. Plasma prekallikrein was contact activated and allowed the splitting of HD-Pro-Phe-Arg-PNA which has affinity for plasma kallikrein. Prothrombin was assayed in various ways (immunologically, after activation with Ecarin or in a less specific way). Determination of factor X is considered as a possible specific method in the monitoring of coumarol therapy.
Similar articles
-
Methods for determination of prekallikrein in plasma, glandular kallikrein and urokinase.Haemostasis. 1978;7(2-3):76-8. doi: 10.1159/000214238. Haemostasis. 1978. PMID: 26629
-
Assay of Fletcher factor (plasma prekallikrein) using an artificial clotting reagent and a modified chromogenic assay.Thromb Haemost. 1979 Aug 31;42(2):538-47. Thromb Haemost. 1979. PMID: 505362
-
Chromogenic substrate assay of plasma prekallikrein. With a note on its site of biosynthesis.Haemostasis. 1978;7(2-3):69-75. doi: 10.1159/000214237. Haemostasis. 1978. PMID: 26628
-
Plasma prekallikrein: quantitative determination by direct activation with Hageman factor fragment (beta-XIIa).J Lab Clin Med. 1983 Feb;101(2):226-41. J Lab Clin Med. 1983. PMID: 6549773
-
Chromogenic peptide substrate assays for determining components of the plasma kallikrein system.Scand J Clin Lab Invest Suppl. 1985;178:127-32. Scand J Clin Lab Invest Suppl. 1985. PMID: 3867113
Cited by
-
A new chromogenic assay for the specific determination of prothrombin.J Clin Pathol. 1979 Jul;32(7):651-4. doi: 10.1136/jcp.32.7.651. J Clin Pathol. 1979. PMID: 500835 Free PMC article.
-
Blood coagulation and fibrinolytic factors and their inhibitors in critically ill patients.Intensive Care Med. 1984;10(1):23-8. doi: 10.1007/BF00258064. Intensive Care Med. 1984. PMID: 6559831